Suchergebnisse - "Mertens, Daniel"

PubPharm (11)

1

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

enthalten in: Nature communications | 2021

von Bloehdorn, J. | Braun, A. | Taylor-Weiner, A. | +31

2

DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy

enthalten in: Scientific data | 2020

von Yosifov, D. | Bloehdorn, J. | Döhner, H. | +3

3

Rapid detection of ATM/p53 function with p27Kip FACS analysis : a novel diagnostic tool for chronic lympocytic leukemia?

enthalten in: Leukemia & lymphoma | 2017

von Meyer-Pannwitt, V. | Steinbrecher, D. | Stilgenbauer, S. | +1

CommentOn: Leuk Lymphoma. 2017 Jan;58(1):199-203. - PMID 27268868

4

Gene mutations and treatment outcome in chronic lymphocytic leukemia : results from the CLL8 trial

enthalten in: Blood | 2014

von Stilgenbauer, S. | Schnaiter, A. | Paschka, P. | +29

CommentIn: Blood. 2014 May 22;123(21):3212-4. - PMID 24855188

5

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab : results from the CLL2H trial of the GCLLSG

enthalten in: Blood | 2013

von Schnaiter, A. | Paschka, P. | Rossi, M. | +13

6

High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations

enthalten in: Blood | 2012

von Edelmann, J. | Holzmann, K. | Miller, F. | +19

7

DNA damage-induced transcriptional program in CLL : biological and diagnostic implications for functional p53 testing

enthalten in: Blood | 2011

von Mohr, J. | Helfrich, H. | Fuge, M. | +10

8

Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk

enthalten in: Haematologica | 2010

von Winkler, D. | Schneider, C. | Zucknick, M. | +12

9

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL) : dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial

enthalten in: Blood | 2009

von Zenz, T. | Häbe, S. | Denzel, T. | +10

10

miR-34a as part of the resistance network in chronic lymphocytic leukemia

enthalten in: Blood | 2009

von Zenz, T. | Mohr, J. | Eldering, E. | +9

CommentIn: Blood. 2009 Apr 16;113(16):3652-3. - PMID 19372264